Match!

Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome

Published on Mar 15, 2018in Biochemical Journal4.331
· DOI :10.1042/BCJ20170604
Eleonora Candi39
Estimated H-index: 39
(University of Rome Tor Vergata),
Manfredi Tesauro31
Estimated H-index: 31
(University of Rome Tor Vergata)
+ 9 AuthorsGerry Melino85
Estimated H-index: 85
(Medical Research Council)
Abstract
Obesity represents one of the most complex public health challenges and has recently reached epidemic proportions.  Obesity is also considered to be primarily responsible for the rising prevalence of metabolic syndrome, defined as the coexistence in the same individual of several risk factors for atherosclerosis, including dyslipidaemia, hypertension and hyperglycaemia, as well as for cancer. Additionally, the presence of three of the five risk factors (abdominal obesity, low HDL cholesterol, high triglycerides, high fasting glucose and high blood pressure) characterizes metabolic syndrome, which has serious clinical consequences.  The current study was conducted in order to identify metabolic differences in visceral adipose tissue collected from obese (BMI 43-48) human subjects who were diagnosed with metabolic syndrome, obese individuals who were metabolically healthy and non-obese healthy controls. Extensive gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS/MS) analyses were used to obtain the untargeted visceral adipose tissue metabolomics profiles of 481 metabolites belonging to all biochemical pathways. Our results indicated consistent increases in oxidative stress markers from the pathologically obese samples in addition to subtle markers of elevated glucose levels that may be consistent with metabolic syndrome. In the tissue derived from the pathologically obese subjects, there were significantly elevated levels of plasmalogens, which may be increased in response to oxidative changes in addition to changes in glycerol-phosphorylcholine, glycerol-phosphorylethanolamine glycerol-phosphorylserine, ceramides and sphingolipids. These data could be potentially helpful for recognizing new pathways that underlie the metabolic-vascular complications of obesity and may lead to the development of innovative targeted therapies.
  • References (61)
  • Citations (7)
📖 Papers frequently viewed together
9 Citations
8 Citations
4 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References61
Newest
Abstract:The heavy impact of obesity on the development and progression of cardiovascular disease has sparked sustained efforts to uncover the mechanisms linking excess adiposity to vascular dysfunction. In addition to its well-established role in maintaining vascular homeostasis, the endothelium ha
14 CitationsSource
Dyslipidaemia is a major contributor to the onset of metabolic disease. Here, Meikle and Summers discuss lipidomic research into relationships between diet, lipid metabolism and metabolic disease. The Review also highlights promising potential therapeutics that target lipid metabolism to counteract obesity, insulin resistance and type 2 diabetes mellitus.
89 CitationsSource
#1Zhenjiang LiuH-Index: 13
#2Lu GanH-Index: 13
Last. Chao SunH-Index: 15
view all 8 authors...
Adiponectin reduces ER stress-induced apoptosis through PPAR α transcriptional regulation of ATF2 in mouse adipose
25 CitationsSource
#1Yi-Ting Wang (NTU: National Taiwan University)H-Index: 1
#2Hou-Hsien Chiang (NTU: National Taiwan University)H-Index: 1
Last. Wei-Shiung YangH-Index: 38
view all 7 authors...
Ribonuclease L (RNase-L) is an endoribonuclease well known for its roles in innate immunity. Recently it has been shown to regulate several cellular functions by modulating the levels of specific mRNAs. In this study, we investigated whether RNase-L may regulate adipocyte functions. We showed that knockdown of RNase-L reduced 3T3-L1 adipocyte differentiation and lipid accumulation. After mRNA profiling, we found that upregulation of Pref-1 mRNA, an inhibitory regulator of adipogenesis, could exp...
3 CitationsSource
#1S. Z. Chen (Fudan University)H-Index: 1
#2L. F. Ning (Fudan University)H-Index: 1
Last. Hai Yan Huang (Fudan University)H-Index: 13
view all 9 authors...
The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling
13 CitationsSource
#1Verena ZollerH-Index: 3
#2Jan-Bernd FunckeH-Index: 8
Last. Pamela Fischer-PosovszkyH-Index: 25
view all 7 authors...
TRAIL (TNF-related apoptosis-inducing ligand) inhibits human adipocyte differentiation via caspase-mediated downregulation of adipogenic transcription factors
14 CitationsSource
#1Di Qi (CQMU: Chongqing Medical University)H-Index: 5
#2Xumao Tang (CQMU: Chongqing Medical University)H-Index: 2
Last. Shenglan Pu (CQMU: Chongqing Medical University)H-Index: 2
view all 11 authors...
Acute respiratory distress syndrome (ARDS) is characterized by increased pulmonary inflammation and endothelial barrier permeability. Omentin has been shown to benefit obesity-related systemic vascular diseases; however, its effects on ARDS are unknown. In the present study, the level of circulating omentin in patients with ARDS was assessed to appraise its clinical significance in ARDS. Mice were subjected to systemic administration of adenoviral vector expressing omentin (Ad-omentin) and one-s...
23 CitationsSource
#1Daniel Andrade Da Cunha (ULB: Université libre de Bruxelles)H-Index: 23
#2Monia Cito (ULB: Université libre de Bruxelles)H-Index: 2
Last. Miriam Cnop (ULB: Université libre de Bruxelles)H-Index: 44
view all 9 authors...
The failure of β-cells has a central role in the pathogenesis of type 2 diabetes, and the identification of novel approaches to improve functional β-cell mass is essential to prevent/revert the disease. Here we show a critical novel role for thrombospondin 1 (THBS1) in β-cell survival during lipotoxic stress in rat, mouse and human models. THBS1 acts from within the endoplasmic reticulum to activate PERK and NRF2 and induce a protective antioxidant defense response against palmitate. Prolonged p...
26 CitationsSource
#1Marta Bagnati (QMUL: Queen Mary University of London)H-Index: 8
#2B W Ogunkolade (QMUL: Queen Mary University of London)H-Index: 8
Last. Turner (NTU: Nottingham Trent University)H-Index: 2
view all 15 authors...
Glucolipotoxicity initiates pancreatic β -cell death through TNFR5/CD40-mediated STAT1 and NF- κ B activation
15 CitationsSource
#1Hanin Aburasayn (U of A: University of Alberta)H-Index: 2
#2Rami Al Batran (U of A: University of Alberta)H-Index: 8
Last. John R. Ussher (U of A: University of Alberta)H-Index: 27
view all 3 authors...
Obesity is a major health concern that increases the risk for insulin resistance, type 2 diabetes (T2D), and cardiovascular disease. Thus, an enormous research effort has been invested into understanding how obesity-associated dyslipidemia and obesity-induced alterations in lipid metabolism increase the risk for these diseases. Accordingly, it has been proposed that the accumulation of lipid metabolites in organs such as the liver, skeletal muscle, and heart is critical to these obesity-induced ...
30 CitationsSource
Cited By7
Newest
#1Vibeke H. Telle-Hansen (Metropolitan University)H-Index: 8
#2Jacob J. Christensen (University of Oslo)H-Index: 5
Last. Stine M. Ulven (University of Oslo)H-Index: 26
view all 5 authors...
BACKGROUND: The ever-increasing prevalence of obesity constitutes a major health problem worldwide. A subgroup of obese individuals has been described as "metabolically healthy obese" (MHO). In contrast to metabolically unhealthy obese (MUO), the MHO phenotype has a favorable risk profile. Despite this, the MHO phenotype is still sub-optimally characterized with respect to a comprehensive risk assessment. Our aim was to increase the understanding of metabolic alterations associated with healthy ...
Source
#1Bingjie Zhou (Tufts University)
#2Reiko Ichikawa (Tufts University)
Last. Chao-Qiang Lai (ARS: Agricultural Research Service)H-Index: 39
view all 10 authors...
Background. Sugar-sweetened beverage (SSB) consumption is highly associated with obesity, but the metabolic mechanism underlying this correlation is not understood. Objective. Our objective was to examine metabolomic links between SSB intake and obesity to understand metabolic mechanisms. Design. We examined the association of plasma metabolomic profiles with SSB intake and obesity risk in 781 participants, aged 45–75 y, in the Boston Puerto Rican Health Study (BPRHS) using generalized linear mo...
Source
BACKGROUND Obesity is a risk factor for colorectal cancer, yet metabolic distinctions between healthy right and left colon tissue, before cancer is diagnosed, remains largely unknown. This study compared right-ascending and left-descending colon tissue metabolomes to identify differences from the stool metabolome in normal weight, overweight, and obese adults.
Source
#1Yujuan XiangH-Index: 3
#2Wenzhong ZhouH-Index: 1
Last. Fei ZhouH-Index: 3
view all 32 authors...
Objective: To investigate the association between metabolic syndrome and breast cancer and to elucidate the potential mechanism underlying this association. Patients and Methods: Based on baseline data drawn from 21 hospitals in 11 provinces of China, we performed a case-control study among 1,127 women (595 cases and 532 controls), divided into premenopausal, and postmenopausal subgroups. Student's t test, Pearson's chi(2) test, and logistic regression analyses were performed to ascertain the as...
Source
#1Zijian Fang (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 1
#2Susan Pyne (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 42
Last. Nigel J. Pyne (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 45
view all 3 authors...
Abstract The increased adipose tissue mass of obese individuals enhances the risk of metabolic syndrome, type 2 diabetes and cardiovascular diseases. During pathological expansion of adipose tissue, multiple molecular controls of lipid storage, adipocyte turn-over and endocrine secretion are perturbed and abnormal lipid metabolism results in a distinct lipid profile. There is a role for ceramides and sphingosine 1-phosphate (S1P) in inducing adipose dysfunction. For instance, the alteration of c...
Source
#1Catherine Do (UNM: University of New Mexico)
#2Bridget M. Ford (University of the Incarnate Word)H-Index: 5
Last. Brent Wagner (UNM: University of New Mexico)H-Index: 10
view all 6 authors...
Abstract Evidence for gadolinium-based contrast agent- (GBCA-) induced disease continues to mount. Risk factors for gadolinium-induced systemic fibrosis are entirely unexplored. Obesity-related renal injury is characterized by activation of glomerular mesangial cells and podocyte damage with alteration of lipid metabolism/lipid accumulation in both cell types resulting in matrix accumulation and eventual progression to glomerulosclerosis. We examined the consequences of GBCA treatment in the kid...
Source
#1Zijian Fang (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 1
#2Susan Pyne (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 42
Last. Nigel J. Pyne (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 45
view all 3 authors...
Abstract The increased adipose tissue mass of obese individuals enhances the risk of metabolic syndrome, type 2 diabetes and cardiovascular diseases. During pathological expansion of adipose tissue, multiple molecular controls of lipid storage, adipocyte turn-over and endocrine secretion are perturbed and abnormal lipid metabolism results in a distinct lipid profile. There is a role for ceramides and sphingosine 1-phosphate (S1P) in inducing adipose dysfunction. For instance, the alteration of c...
1 CitationsSource
#1Carla Iacobini (Sapienza University of Rome)H-Index: 25
#2G. Polese (Sapienza University of Rome)H-Index: 84
Last. Stefano Menini (Sapienza University of Rome)H-Index: 32
view all 5 authors...
Abstract Obesity-related disease complications reduce life quality and expectancy and increase health-care costs. Some studies have suggested that obesity not always entails metabolic abnormalities and increased risk of cardiometabolic complications. Because of the lack of universally accepted criteria to identify metabolically healthy obesity (MHO), its prevalence varies widely among studies. Moreover, the prognostic value of MHO is hotly debated, mainly because it likely shifts gradually towar...
9 CitationsSource
#1Johana M. Lambert (MUSC: Medical University of South Carolina)H-Index: 1
#2Andrea K. Anderson (MUSC: Medical University of South Carolina)H-Index: 1
Last. L. Ashley Cowart (VCU: Virginia Commonwealth University)H-Index: 2
view all 3 authors...
Abstract Adipose tissue lies at the heart of obesity, mediating its many effects upon the rest of the body, with its unique capacity to expand and regenerate, throughout the lifespan of the organism. Adipose is appreciated as an endocrine organ, with its myriad adipokines that elicit both physiological and pathological outcomes. Sphingolipids, bioactive signaling molecules, affect many aspects of obesity and the metabolic syndrome. While sphingolipids are appreciated in the context of these dise...
Source
#1Abdelaziz GhanemiH-Index: 3
#2Mayumi YoshiokaH-Index: 21
Last. Jonny St-AmandH-Index: 12
view all 3 authors...
Obesity represents an abnormal fat accumulation resulting from energy imbalances. It represents a disease with heavy consequences on population health and society economy due to its related morbidities and epidemic proportion. Defining and classifying obesity and its related parameters of evaluation is the first challenge toward understanding this multifactorial health problem. Therefore, within this review we report selected illustrative examples of the underlying mechanisms beyond the obesity ...
2 CitationsSource